Document Detail


Best strategies for global HCV eradication.
MedLine Citation:
PMID:  23286849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Worldwide eradication of hepatitis C virus (HCV) is possible through a combination of prevention education, universal clinical and targeted community screening, effective linkage to care and treatment with promising new direct-acting antiviral drug regimens. Universal screening should be offered in all healthcare visits, and parallel community screening efforts should prioritize high-prevalence, high-transmission populations including injection drug users, prison inmates and those with HIV/HCV co-infection. Increasing awareness of HCV infection through screening, improving treatment uptake and cure rates by providing linkage to care and more effective treatment, and ultimately combining education efforts with vaccination campaigns to prevent transmission and reinfection can slow and eventually stop the 'silent epidemic'.
Authors:
Liesl M Hagan; Raymond F Schinazi
Related Documents :
24687129 - Association between mycoplasma genitalium infection and hiv acquisition among female se...
24841129 - Low-grade proteinuria is highly prevalent in hiv-positive patients on antiretroviral tr...
2302009 - Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone m...
23242159 - Factors associated with resumption of sex before complete wound healing in circumcised ...
24755089 - Prevalence and trends of markers of hepatitis b virus, hepatitis c virus and human immu...
23161209 - Hiv knowledge and sexual risk behavior among pregnant couples in south africa: the part...
11511819 - Evolution of cervical abnormalities among women with hiv-1: evidence from surveillance ...
22676879 - Modelling antiviral treatment to prevent hepatitis c infection among people who inject ...
23235059 - The effect on survival of a multidimensional intervention project (sead) in hiv/aids pa...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review    
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  33 Suppl 1     ISSN:  1478-3231     ISO Abbreviation:  Liver Int.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-04     Completed Date:  2013-06-14     Revised Date:  2014-07-25    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  68-79     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / therapeutic use*
Delivery of Health Care, Integrated
Health Education
Health Knowledge, Attitudes, Practice
Health Services Accessibility
Hepatitis C, Chronic / diagnosis,  epidemiology,  prevention & control*,  transmission
Humans
Mass Screening* / methods
Patient Acceptance of Health Care
Predictive Value of Tests
Public Opinion
Risk Assessment
Risk Factors
Risk Reduction Behavior*
Viral Hepatitis Vaccines*
Vulnerable Populations
World Health*
Grant Support
ID/Acronym/Agency:
2P30-AI-050409/AI/NIAID NIH HHS; P30 AI050409/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Viral Hepatitis Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  HCV therapy in HIV-infected patients.
Next Document:  New therapeutic strategies in HCV: second-generation protease inhibitors.